An MR analysis using rs11977526 as the IV, revealed that a large increase in the concentration of IGF‐II or IGFBP‐3 (∼1 SD) would increase the likelihood of progression to high grade cancer by approximately 15%, whilst a similar increase in IGF‐I levels would be protective against disease progression. The gene discussed is IGF2; the disease is cancer.